Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for non-ST-elevation myocardial infarction
IRCT20220516054874N4Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Non-ST-segment elevation myocardial infarction (NSTEMI) comparing Montelukast plus common treatment with Placebo plus common treatment (2 arms). Primary endpoint: Change in hs-CRP. Started Aug 2022; status: completed.
02
Drugs
montelukast
03
Conditions
Non-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on IRCT20220516054874N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220516054874N4.